Congenital isolated hyperinsulinism

MONDO:0019010

Congenital isolated hyperinsulinism (CHI), a rare endocrine disease is the most frequent cause of severe and persistent hypoglycemia in the neonatal period and early infancy and is characterized by an excessive or uncontrolled insulin secretion (inappropriate for the level of glycemia) and recurrent episodes of profound hypoglycemia requiring rapid and intensive treatment to prevent neurological sequelae. CHI comprises 2 different forms: diazoxide-sensitive diffuse hyperinsulinism and diazoxide-resistant hyperinsulinism.

Also known as: Congenital Hyperinsulinism, PHHI, chi, persistent hyperinsulinemic hypoglycemia of infancy, congenital hyperinsulinism, hyperinsulinemic hypoglycemia familial, hyperinsulinism congenital, hyperinsulinism familial with pancreatic nesidioblastosis

41 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Sub-types

Broader categories

Sort by